Avidity Biosciences, Inc. (RNA)
NASDAQ: RNA · Real-Time Price · USD
41.06
-0.75 (-1.79%)
At close: Sep 19, 2025, 4:00 PM EDT
41.68
+0.62 (1.51%)
After-hours: Sep 19, 2025, 5:26 PM EDT

Avidity Biosciences Statistics

Total Valuation

RNA has a market cap or net worth of $5.90 billion. The enterprise value is $4.72 billion.

Market Cap5.90B
Enterprise Value 4.72B

Important Dates

The next estimated earnings date is Thursday, November 6, 2025, after market close.

Earnings Date Nov 6, 2025
Ex-Dividend Date n/a

Share Statistics

RNA has 143.65 million shares outstanding. The number of shares has increased by 48.40% in one year.

Current Share Class 143.65M
Shares Outstanding 143.65M
Shares Change (YoY) +48.40%
Shares Change (QoQ) +0.30%
Owned by Insiders (%) 0.90%
Owned by Institutions (%) 84.41%
Float 120.40M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 549.76
Forward PS 720.81
PB Ratio 4.16
P/TBV Ratio 4.95
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 439.97
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 9.26, with a Debt / Equity ratio of 0.00.

Current Ratio 9.26
Quick Ratio 8.82
Debt / Equity 0.00
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -37.76% and return on invested capital (ROIC) is -26.87%.

Return on Equity (ROE) -37.76%
Return on Assets (ROA) -24.01%
Return on Invested Capital (ROIC) -26.87%
Return on Capital Employed (ROCE) -42.29%
Revenue Per Employee $27,440
Profits Per Employee -$1.17M
Employee Count391
Asset Turnover 0.01
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -8.00% in the last 52 weeks. The beta is 0.99, so RNA's price volatility has been similar to the market average.

Beta (5Y) 0.99
52-Week Price Change -8.00%
50-Day Moving Average 41.63
200-Day Moving Average 33.58
Relative Strength Index (RSI) 44.33
Average Volume (20 Days) 4,031,554

Short Selling Information

Short Interest 17.57M
Short Previous Month 15.67M
Short % of Shares Out 13.78%
Short % of Float n/a
Short Ratio (days to cover) 5.27

Income Statement

In the last 12 months, RNA had revenue of $10.73 million and -$455.74 million in losses. Loss per share was -$3.57.

Revenue10.73M
Gross Profit -399.71M
Operating Income -521.78M
Pretax Income -228.68M
Net Income -455.74M
EBITDA -518.74M
EBIT -521.78M
Loss Per Share -$3.57
Full Income Statement

Balance Sheet

The company has $1.18 billion in cash and $5.14 million in debt, giving a net cash position of $1.18 billion or $8.20 per share.

Cash & Cash Equivalents 1.18B
Total Debt 5.14M
Net Cash 1.18B
Net Cash Per Share $8.20
Equity (Book Value) 1.19B
Book Value Per Share 9.87
Working Capital 1.12B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$489.98 million and capital expenditures -$12.72 million, giving a free cash flow of -$502.70 million.

Operating Cash Flow -489.98M
Capital Expenditures -12.72M
Free Cash Flow -502.70M
FCF Per Share -$3.50
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin -4,863.29%
Pretax Margin -4,247.76%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

RNA does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -48.40%
Shareholder Yield -48.40%
Earnings Yield -7.73%
FCF Yield -8.52%

Analyst Forecast

The average price target for RNA is $69.81, which is 70.02% higher than the current price. The consensus rating is "Strong Buy".

Price Target $69.81
Price Target Difference 70.02%
Analyst Consensus Strong Buy
Analyst Count 16
Revenue Growth Forecast (5Y) 160.49%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

RNA has an Altman Z-Score of 13.15.

Altman Z-Score 13.15
Piotroski F-Score n/a